The EUFEMED family is offering the exciting, post pandemic opportunity to meet face to face once again.
The 2023 biannual EUFEMED conference in Berlin marks an important milestone in our journey back to normalcy.
We are excited to reconnect and share our insights, experiences, and expertise while also being able to network, collaborate, and learn from one another in person. Our conference will be your chance to catch up with old friends and colleagues, make new connections, and discuss the latest trends, challenges and innovations.
EUFEMED is a federation of European organizations and associations active in early clinical medicines development since 2007. A successful collaboration of national bodies, EUFEMED strives to be a voice in the interest of exploratory medicines development.
EUFEMED promotes the interest of early clinical medicines development in professional organizations, international organizations and regulatory authorities. Our aims are to support stakeholders and facilitate networking through conferences, courses and specialist training. We also collaborate with other organizations to develop standards and promote guidance in early medicines development in order to improve European competitiveness.
Our conference are well attended from across the industry and we invite you to take the opportunity to meet our members in a learning environment.
Sybille Baumann (AGAH)
Nariné Biarian (HEALIXIA)
Kerstin Breithaupt-Grögler (AGAH)
Henri Caplain (AFPT)
Izaak den Daas (ACRON)
Yves Donazzolo (AFPT)
Tim Hardman (AHPPI)
Jan de Hoon (HEALIXIA)
Ingrid Klingmann (AGAH)
Andreas Kovar (AGAH)
Erik Mannaert (HEALIXIA)
Paul Goldsmith (AHPPI)
Rob Zuiker (ACRON)
submission deadline extended
19 April, 2023 >>
Attend the conference >>
24 May, 2023 >>
Get more information with at the program >>